In vitro silencing of RXFP1 results in insensitivity to exogenous relaxin, an effect which is reversed by enhancement of RXFP1 expression in both control and IPF lung fibroblasts [17]. The gene discussed is RXFP1; the disease is idiopathic pulmonary fibrosis.